Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
Oncol Rep
    September 2024
  1. CAMESELLE-GARCIA S, Abdulkader-Nallib I, Sanchez-Ares M, Cameselle-Teijeiro JM, et al
    Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review).
    Oncol Rep. 2024;52:119.
    >> Share

    June 2024
  2. XIONG Y, Wang J, Zhu H, Liu L, et al
    [Retracted] Chronic oxymatrine treatment induces resistance and epithelial?mesenchymal transition through targeting the long non?coding RNA MALAT1 in colorectal cancer cells.
    Oncol Rep. 2024;51:73.
    >> Share

  3. ZHANG J, Wang Y, Hou S, Chi X, et al
    Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1.
    Oncol Rep. 2024;51:82.
    >> Share

  4. LIU W, Qian K, Wei X, Deng H, et al
    [Corrigendum] miR?27a promotes proliferation, migration, and invasion of colorectal cancer by targeting FAM172A and acts as a diagnostic and prognostic biomarker.
    Oncol Rep. 2024;51:83.
    >> Share

    May 2024
  5. ZHANG X, He L, Li Y, Qiu Y, et al
    Compound 225# inhibits the proliferation of human colorectal cancer cells by promoting cell cycle arrest and apoptosis induction.
    Oncol Rep. 2024;51:70.
    >> Share

    April 2024
  6. SUSANTO AC, Hartajanie L, Wu CC
    alpha?Phellandrene enhances the apoptosis of HT?29 cells induced by 5?fluorouracil by modulating the mitochondria?dependent pathway.
    Oncol Rep. 2024;51:61.
    >> Share

    March 2024
  7. LI XL, Zhou J, Xia CJ, Min H, et al
    [Corrigendum] PRIMA?1(met) induces autophagy in colorectal cancer cells through upregulation of the mTOR/AMPK?ULK1?Vps34 signaling cascade.
    Oncol Rep. 2024;51:44.
    >> Share

    February 2024
  8. ZHANG M, Xiang F, Sun Y, Liu R, et al
    Ursolic acid inhibits the metastasis of colon cancer by downregulating ARL4C expression.
    Oncol Rep. 2024;51:27.
    >> Share

  9. CHO SJ, Jeong BY, Yoon SH, Park CG, et al
    Rab25 suppresses colon cancer cell invasion through upregulating claudin?7 expression.
    Oncol Rep. 2024;51:26.
    >> Share

  10. CAO R, Guo S, Min L, Li P, et al
    Roles of Rictor alterations in gastrointestinal tumors (Review).
    Oncol Rep. 2024;51:37.
    >> Share

    January 2024
  11. CHI J, Liu S, Wu Z, Shi Y, et al
    [Retracted] circNSUN2 promotes the malignant biological behavior of colorectal cancer cells via the miR?181a?5p/ROCK2 axis.
    Oncol Rep. 2024;51:13.
    >> Share

  12. LU M, Hu X, Cheng C, Zhang Y, et al
    RPF2 mediates the CARM1?MYCN axis to promote chemotherapy resistance in colorectal cancer cells.
    Oncol Rep. 2024;51:11.
    >> Share

    December 2023
  13. ZHANG J, Li C, Sun L, Sun D, et al
    P53?microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions.
    Oncol Rep. 2023;50:219.
    >> Share

    November 2023
  14. DING M, Yan J, Chao G, Zhang S, et al
    Application of artificial intelligence in colorectal cancer screening by colonoscopy: Future prospects (Review).
    Oncol Rep. 2023;50:199.
    >> Share

    October 2023
  15. SIM MK, Park JE, Kim SR, Lee J, et al
    Neuromedin U contributes to radiation resistance in colorectal cancer via YAP/TAZ signaling activation.
    Oncol Rep. 2023;50:178.
    >> Share

  16. ALZAHRANI SM, Al Doghaither HA, Al-Ghafari AB, Pushparaj PN, et al
    5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review).
    Oncol Rep. 2023;50:175.
    >> Share

  17. YAMAMOTO T, Shiburo R, Moriyama Y, Mitamura K, et al
    Protein components of maple syrup as a potential resource for the development of novel anti‑colorectal cancer drugs.
    Oncol Rep. 2023;50:179.
    >> Share

  18. CHEN WS, Zhang X, Zhao ZF, Che XM, et al
    MBNL1?AS1 attenuates tumor cell proliferation by regulating the miR?29c?3p/BVES signal in colorectal cancer.
    Oncol Rep. 2023;50:191.
    >> Share

    September 2023
  19. LIU Z, Fan L, Niu D, Chen M, et al
    Copper (II) complex of salicylate phenanthroline induces the apoptosis of colorectal cancer cells, including oxaliplatin‑resistant cells.
    Oncol Rep. 2023;50:170.
    >> Share

    July 2023
  20. FENG WQ, Zhang YC, Gao H, Li WC, et al
    FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through beta‑catenin nuclear localization.
    Oncol Rep. 2023;50:134.
    >> Share

  21. TANG B, Liang W, Liao Y, Li Z, et al
    [Retracted] PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.
    Oncol Rep. 2023;50:137.
    >> Share

    June 2023
  22. MA F, Lin Y, Ni Z, Chen T, et al
    Therapeutic effects of natural polyphenols on colorectal adenomas: Focus on preclinical studies (Review).
    Oncol Rep. 2023;49:112.
    >> Share

  23. ZHOU J, Chen S, Liu J, Du J, et al
    Knockdown of hnRNPAB reduces the stem cell properties and enhances the chemosensitivity of human colorectal cancer stem cells.
    Oncol Rep. 2023;49:129.
    >> Share

  24. GONG JE, Kim JE, Park SH, Lee SJ, et al
    Anti‑tumor effects of an aqueous extract of Ecklonia cava in BALB/cKorl syngeneic mice using colon carcinoma CT26 cells.
    Oncol Rep. 2023;49:128.
    >> Share

    May 2023
  25. WANG C, Xin H, Yan G, Liu Z, et al
    NONHSAG028908.3 sponges miR‑34a‑5p to promote growth of colorectal cancer via targeting ALDOA.
    Oncol Rep. 2023;49:89.
    >> Share

  26. SUN LB, Zhao SF, Zhu JJ, Han Y, et al
    [Retracted] Long noncoding RNA UCID sponges miR‑152‑3p to promote colorectal cancer cell migration and invasion via the Wnt/beta‑catenin signaling pathway.
    Oncol Rep. 2023;49:92.
    >> Share

  27. QIAN K, Zhang J, Lu J, Liu W, et al
    [Retracted] FAM172A modulates apoptosis and proliferation of colon cancer cells via STAT1 binding to its promoter.
    Oncol Rep. 2023;49:107.
    >> Share

    April 2023
  28. KANG M, Su Z
    Increased expression of GIPC2 in colon adenocarcinoma is associated with a favorable prognosis and high levels of immune cell infiltration.
    Oncol Rep. 2023;49:66.
    >> Share

  29. KIM HJ, Hong I, Roh S, Kim S, et al
    High expression of LY6E is an independent prognostic factor of colorectal cancer patients.
    Oncol Rep. 2023;49:80.
    >> Share

    March 2023
  30. HARATA S, Suzuki T, Takahashi H, Hirokawa T, et al
    AZD6738 promotes the tumor suppressive effects of trifluridine in colorectal cancer cells.
    Oncol Rep. 2023;49:52.
    >> Share

  31. XIE Y, Zhang Y, Liu X, Cao L, et al
    miR‑151a‑5p promotes the proliferation and metastasis of colorectal carcinoma cells by targeting AGMAT.
    Oncol Rep. 2023;49:50.
    >> Share

  32. KIM JE, Lee SK, Park J, Jung MJ, et al
    Buddlejasaponin IV induces apoptotic cell death by activating the mitochondrial‑dependent apoptotic pathway and reducing alpha(2)beta(1) integrin‑mediated adhesion in HT‑29 human colorectal cancer cells.
    Oncol Rep. 2023;49:58.
    >> Share

    February 2023
  33. LINDEMANN A, Brandes F, Borrmann M, Meidert AS, et al
    Anesthetic‑specific lncRNA and mRNA profile changes in blood during colorectal cancer resection: A prospective, matched‑case pilot study.
    Oncol Rep. 2023;49:28.
    >> Share

  34. LOMBARDI P, Aimar G, Peraldo-Neia C, Bonzano A, et al
    Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT).
    Oncol Rep. 2023;49:31.
    >> Share

  35. JIANG T, Li H, Jiang R, Li H, et al
    [Retracted] Pin2/TRF1‑binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factor‑kappaB signaling pathway.
    Oncol Rep. 2023;49:40.
    >> Share

    January 2023
  36. TANG Y, Yi X, Zhang X, Liu B, et al
    Microcystin‑leucine arginine promotes colorectal cancer cell proliferation by activating the PI3K/Akt/Wnt/beta‑catenin pathway.
    Oncol Rep. 2023;49:18.
    >> Share

  37. ROSTKOWSKA O, Olejniczak-Keder A, Spychalski P, Szarynska M, et al
    Triiodothyronine lowers the potential of colorectal cancer stem cells in vitro.
    Oncol Rep. 2023;49:21.
    >> Share

    November 2022
  38. URH K, Zidar N, Tomazic A, Bostjancic E, et al
    Intratumor heterogeneity of cancer stem cellrelated genes and their potential regulatory microRNAs in metastasizing colorectal carcinoma.
    Oncol Rep. 2022;48.
    >> Share

  39. LIU F, Su D, Zhang H, Lin HC, et al
    Clinical implications of the oralgut microbiome axis and its association with colorectal cancer (Review).
    Oncol Rep. 2022;48.
    >> Share

  40. CIZAUSKAITE A, Simcikas D, Schultze D, Kallifatidis G, et al
    Sulforaphane has an additive anticancer effect to FOLFOX in highly metastatic human colon carcinoma cells.
    Oncol Rep. 2022;48.
    >> Share

    October 2022
  41. LIU X, Wang Y, Zhao J
    [Retracted] MicroRNA337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
    Oncol Rep. 2022;48.
    >> Share

  42. SI Y, Li L, Zhang W, Liu Q, et al
    GANT61 exerts anticancer cell and anticancer stem cell capacity in colorectal cancer by blocking the Wnt/betacatenin and Notch signalling pathways.
    Oncol Rep. 2022;48.
    >> Share

    June 2022
  43. DAITOKU N, Miyamoto Y, Hiyoshi Y, Tokunaga R, et al
    Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer.
    Oncol Rep. 2022;47.
    >> Share

  44. NAKAI N, Hara M, Takahashi H, Shiga K, et al
    Cancer cellinduced tissue inhibitor of metalloproteinase1 secretion by cancerassociated fibroblasts promotes cancer cell migration.
    Oncol Rep. 2022;47.
    >> Share

    May 2022
  45. SATO N, Sakai N, Furukawa K, Takayashiki T, et al
    Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer.
    Oncol Rep. 2022;47.
    >> Share

  46. ZHAO P, Zhou P, Tang T, Si R, et al
    Levels of circulating mast cell progenitors and tumourinfiltrating mast cells in patients with colorectal cancer.
    Oncol Rep. 2022;47.
    >> Share

  47. LEE MH, Hong SH, Park C, Kim GY, et al
    [Corrigendum] Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathway.
    Oncol Rep. 2022;47.
    >> Share

  48. XU Y, Liu X, Zhang H, Zhu Z, et al
    [Corrigendum] Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/beta-catenin signaling pathway in colorectal cancer.
    Oncol Rep. 2022;47.
    >> Share

  49. YOSHIMOTO T, Shimada M, Tokunaga T, Nakao T, et al
    Blue light irradiation inhibits the growth of colon cancer and activation of cancerassociated fibroblasts.
    Oncol Rep. 2022;47.
    >> Share

    April 2022
  50. LI J, Xu J, Yan X, Jin K, et al
    [Retracted] MicroRNA485 plays tumoursuppressive roles in colorectal cancer by directly targeting GAB2.
    Oncol Rep. 2022;47.
    >> Share

  51. HAN J, Liu Z, Wang N, Pan W, et al
    [Retracted] MicroRNA874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting Xlinked inhibitor of apoptosis protein.
    Oncol Rep. 2022;47.
    >> Share

  52. ZHAO J, Xu J, Zhang R
    [Retracted] MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
    Oncol Rep. 2022;47.
    >> Share

  53. SUZUKI T, Hirokawa T, Maeda A, Harata S, et al
    ATR inhibitor AZD6738 increases the sensitivity of colorectal cancer cells to 5fluorouracil by inhibiting repair of DNA damage.
    Oncol Rep. 2022;47.
    >> Share

    March 2022
  54. YAN Z, Zhou Y, Yang Y, Zeng C, et al
    Zinc finger protein 384 enhances colorectal cancer metastasis by upregulating MMP2.
    Oncol Rep. 2022;47.
    >> Share

    February 2022
  55. ZHANG S, Yu M, Chen D, Li P, et al
    Role of MRIbased radiomics in locally advanced rectal cancer (Review).
    Oncol Rep. 2022;47.
    >> Share

    January 2022
  56. ZEYA B, Nafees S, Imtiyaz K, Uroog L, et al
    Diosmin in combination with naringenin enhances apoptosis in colon cancer cells.
    Oncol Rep. 2022;47.
    >> Share

  57. CHEN W, Dai G, Qian Y, Wen L, et al
    PIK3CA mutation affects the proliferation of colorectal cancer cells through the PI3K-MEK/PDK1-GPT2 pathway.
    Oncol Rep. 2022;47.
    >> Share

  58. TAK E, Kim M, Cho Y, Choi S, et al
    Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance.
    Oncol Rep. 2022;47.
    >> Share

    December 2021
  59. XIE Y, Wang F, Yu J, Zhang J, et al
    Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP.
    Oncol Rep. 2021;46.
    >> Share

    November 2021
  60. LI Y, Qian X, Lin Y, Tao L, et al
    Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment.
    Oncol Rep. 2021;46.
    >> Share

    August 2021
  61. ASANO T, Ohishi T, Takei J, Nakamura T, et al
    AntiHER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
    Oncol Rep. 2021;46.
    >> Share

    June 2021
  62. ZHANG YL, Wen XD, Guo X, Huang SQ, et al
    Progesterone suppresses the progression of colonic carcinoma by increasing the activity of the GADD45alpha/JNK/cJun signalling pathway.
    Oncol Rep. 2021;45.
    >> Share

    May 2021
  63. FREUND E, Miebach L, Stope MB, Bekeschus S, et al
    Hypochlorous acid selectively promotes toxicity and the expression of danger signals in human abdominal cancer cells.
    Oncol Rep. 2021;45.
    >> Share

    March 2021
  64. SZCZYGIEL A, Anger-Gora N, Wegierek-Ciura K, Mierzejewska J, et al
    Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cellbased vaccines in murine colon carcinoma.
    Oncol Rep. 2021;45:945-962.
    >> Share

  65. VERDINA A, Di Segni M, Amoreo CA, Sperduti I, et al
    HIPK2 is a potential predictive marker of a favorable response for adjuvant chemotherapy in stage II colorectal cancer.
    Oncol Rep. 2021;45:899-910.
    >> Share

  66. WANG X, Song Z, Hu B, Chen Z, et al
    MicroRNA‑642a‑5p inhibits colon cancer cell migration and invasion by targeting collagen type I alpha1.
    Oncol Rep. 2021;45:933-944.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016